issue in the present appeals is regarding valuation of the
'physician samples' manufactured by the Appellant and sold on principal
to principal basis ... Srushti Pharmaceuticals Pvt., Ltd, the
Appellant is manufacturing 'physicians samples' under 'principal to
principal' basis for other 'pharmaceutical manufacturers/brand
issue in the present appeals is regarding valuation of the
'physician samples' manufactured by the Appellant and sold on principal
to principal basis ... Srushti Pharmaceuticals Pvt., Ltd, the
Appellant is manufacturing 'physicians samples' under 'principal to
principal' basis for other 'pharmaceutical manufacturers/brand
issue in the present appeals is regarding valuation of the
'physician samples' manufactured by the Appellant and sold on principal
to principal basis ... Srushti Pharmaceuticals Pvt., Ltd, the
Appellant is manufacturing 'physicians samples' under 'principal to
principal' basis for other 'pharmaceutical manufacturers/brand
appellant was
clearing their products meant for free distribution as 'Physician
Samples' computing the assessable value adopting Cost
Construction Method in accordance with ... Rules, 2000; the
appellant was directed to discharge duty on free physician
samples adopting Rule 4 of the said Valuation Rules
CETA, 1985.
They cleared P or P medicaments as physician samples on payment of
duty by adopting value under Rule 4 of the Central Excise ... 2002 CX dated 1.7.2002 clarified that in
2
respect of physician samples, which were distributed free, the
assessable value would
CETA, 1985.
They cleared P or P medicaments as physician samples on payment of
duty by adopting value under Rule 4 of the Central Excise ... 2002 CX dated 1.7.2002 clarified that in
2
respect of physician samples, which were distributed free, the
assessable value would
CETA, 1985.
They cleared P or P medicaments as physician samples on payment of
duty by adopting value under Rule 4 of the Central Excise ... 2002 CX dated 1.7.2002 clarified that in
2
respect of physician samples, which were distributed free, the
assessable value would
CETA, 1985.
They cleared P or P medicaments as physician samples on payment of
duty by adopting value under Rule 4 of the Central Excise ... 2002 CX dated 1.7.2002 clarified that in
2
respect of physician samples, which were distributed free, the
assessable value would
CETA, 1985.
They cleared P or P medicaments as physician samples on payment of
duty by adopting value under Rule 4 of the Central Excise ... 2002 CX dated 1.7.2002 clarified that in
2
respect of physician samples, which were distributed free, the
assessable value would
CETA, 1985.
They cleared P or P medicaments as physician samples on payment of
duty by adopting value under Rule 4 of the Central Excise ... 2002 CX dated 1.7.2002 clarified that in
2
respect of physician samples, which were distributed free, the
assessable value would
